Clinical Trials
28 trialsComparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Oslo University Hospital
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Lanzhou University Second Hospital
microDRIVE
Pacific Edge Limited
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Tel-Aviv Sourasky Medical Center
MicroBlad
University Hospital, Toulouse
Korean Prospective Upper Tract Urothelial Carcinoma Cohort
Samsung Medical Center
Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
Tianjin Medical University Second Hospital
P-EVOLUTION
Comprehensive Cancer Center Munich (CCCM)
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
Dana-Farber Cancer Institute
SOGUG-PRINCIS
Spanish Oncology Genito-Urinary Group
WASHOUT
British Urology Researchers in Surgical Training
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center
FLORAL
University Hospital, Strasbourg, France
OUAF
University Hospital, Strasbourg, France
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
Peking University First Hospital
BLUSH
Vastra Gotaland Region
INSITE
Fox Chase Cancer Center
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
UROSCOUT-1
Tampere University Hospital
CARAT
iOMEDICO AG
ST-ICI02
University of Erlangen-Nürnberg Medical School
Urolife
IRCCS San Raffaele
ARON-2 Study-Multicentric International Retrospective Study
Hospital of Macerata
A Multicenter Cancer Biospecimen Collection Study
Cofactor Genomics, Inc.
uTRACT
UroGen Pharma Ltd.
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
Urine Omics Predicting IO Therapy Responses in mUC Patients
National Taiwan University Hospital
CIRCE
IRCCS San Raffaele